Kimberly-Clark explores sale of its international tissue business, Bloomberg News reports-February 2024-www.financetom.com

Kimberly-Clark explores sale of its international tissue business, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Kimberly-Clark explores sale of its international tissue business, Bloomberg News reports

Oct 2, 2024 11:42 PM

Sept 30 (Reuters) - Kimberly-Clark ( KMB ) is exploring

the sale of its international tissue business, Bloomberg News

said on Monday, citing people familiar with the matter.

A potential deal could value the business at about $4

billion, the report added.

Previous page： Former Goldman, Blackstone analyst gets 28-month prison sentence for insider trading Next page： 4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Former Goldman, Blackstone analyst gets 28-month prison sentence for insider trading

Jul 17, 2024

NEW YORK, July 17 (Reuters) - A former Goldman Sachs and Blackstone analyst was sentenced to 28 months in prison on Wednesday for insider trading, after admitting that his conduct was catastrophically stupid. Anthony Viggiano, 27, of Baldwin, New York, was sentenced by U.S. District Judge Valerie Caproni in Manhattan, after pleading guilty in January to securities fraud. Viggiano was...

4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate

Jul 17, 2024

Wednesday, 4D Molecular Therapeutics, Inc. ( FDMT )unveiled interim 24-week data from the Population Extension cohort of its PRISM Phase 2 Clinical Trial. The trial evaluates intravitreal 4D-150 in a broad wet AMD patient population. Also Read: Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released. The findings were presented at the American Society...

-- Altius Renewable Royalties Brief: Reporting Q2 2024 Expected Proportionate Royalty Revenue of US$1.5 million

Jul 17, 2024

02:24 PM EDT, 07/17/2024 (MT Newswires) -- Price: 9.33, Change: -0.08, Percent Change: -0.85 ...

Stellantis Extends, Amends $13.12 Billion Credit Facility

Jul 17, 2024

02:23 PM EDT, 07/17/2024 (MT Newswires) -- Stellantis ( STLA ) said Wednesday it has extended its 12 billion euros ($13.12 billion) syndicated revolving credit facility. The credit facility, originally signed in July 2021, involves 29 banks from Europe, America, and Asia. It is divided into two tranches: 6 billion euros with a three-year term and 6 billion euros with...